PUBLICATION

A functional genomics approach to the mode of action of apratoxin A

Authors
Luesch, H., Chanda, S.K., Raya, R.M., Dejesus, P.D., Orth, A.P., Walker, J.R., Izpisúa Belmonte, J.C., and Schultz, P.G.
ID
ZDB-PUB-060216-7
Date
2006
Source
Nature Chemical Biology   2(3): 158-167 (Journal)
Registered Authors
Izpisúa Belmonte, Juan Carlos
Keywords
none
MeSH Terms
  • Animals
  • Apoptosis/drug effects
  • Cell Cycle/drug effects*
  • Cell Cycle/genetics
  • Cell Proliferation/drug effects
  • Depsipeptides/pharmacology*
  • Drug Resistance, Neoplasm
  • Endothelial Cells/drug effects
  • Fibroblast Growth Factors/antagonists & inhibitors
  • Fibroblast Growth Factors/metabolism
  • G1 Phase/drug effects
  • Gene Expression Regulation/drug effects
  • Genomics/methods*
  • Humans
  • In Vitro Techniques
  • Molecular Conformation
  • Phosphorylation
  • RNA, Messenger/drug effects
  • RNA, Messenger/genetics
  • STAT3 Transcription Factor/drug effects
  • STAT3 Transcription Factor/metabolism
  • Signal Transduction/drug effects
  • Signal Transduction/physiology
  • Structure-Activity Relationship
  • Transcription, Genetic/drug effects
  • Tumor Cells, Cultured
  • Zebrafish/embryology
PubMed
16474387 Full text @ Nat. Chem. Biol.
Abstract
The cyanobacterial metabolite apratoxin A (1) demonstrates potent cytotoxicity against tumor cell lines by a hitherto unknown mechanism. We have used functional genomics to elucidate the molecular basis for this activity. Gene expression profiling and DNA content analysis showed that apratoxin A induces G1-phase cell cycle arrest and apoptosis. Cell-based functional assays with a genome-wide collection of expression cDNAs showed that ectopic induction of fibroblast growth factor receptor (FGFR) signaling attenuates the apoptotic activity of apratoxin A. This natural product inhibited phosphorylation and activation of STAT3, a downstream effector of FGFR signaling. It also caused defects in FGF-dependent processes during zebrafish development, with concomitant reductions in expression levels of the FGF target gene mkp3. We conclude that apratoxin A mediates its antiproliferative activity through the induction of G1 cell cycle arrest and an apoptotic cascade, which is at least partially initiated through antagonism of FGF signaling via STAT3.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping